Class Action Article

  • File A Talcum Powder Lawsuit: Talcum Powder Ovarian Cancer Lawsuits Talcum Powder Fallopian Tube Cancer Lawsuits Baby  Powder Ovarian Cancer Lawsuits Filed If you or a loved one used talcum powder products and were diagnosed with ovarian cancer, or fallopian tube can...

Class Action News

Drug Class Actions

  • Taxotere Lawyers for Permanent Hair Loss: Taxotere Baldness Lawyers For  Permanent Hair Loss Lawsuits Have you received Taxotere for breast cancer? Taxotere can result in hair loss or baldness  that is permanent. Taxotere  is a chemotherapy drug used for the treatment of breas...

Medical Device Lawsuits

  • Zimmer Hip Replacement Lawyers: Network Zimmer Hip Replacement  Lawyer Win $2 Million Against Zimmer Hip Replacement Do You Have A Faulty Zimmer M/L Taper Hip Prothesis With Connective Technology and Cobalt Chromium Head? Do You Have Have Metallosis or Chromium Cobalt T...

Posts Tagged ‘blood clots from yaz’

Did You Take Yaz Or Yasmin? Settlements For Yaz Lawsuits For Bloodclots

Written by lisaspitzer on . Posted in Class MDL Class Action News

Yaz, Yasmin Lawsuit  Multidistrict Litigation


MDL 2100 – Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, multidistrict litigation (MDL) in Illinois federal court.


Yaz lawyers are accepting Yaz lawsuits for blood clot related injuries:

  • Pulmonary Embolism
  • Blood Clots
  • Stokes
  • Deep Vein Thrombosis

Bayer is facing thousands of Yaz and Yasmin lawsuits involving blood clot related injuries.

Yaz Blood Clot Settlements

According to Bayer’s 2nd Quarter 2013 Statement, Bayer  haa agreed to pay more than $1.4 billion to resolve an estimated 6,700 lawsuits from women  who suffered a:
    Heart attack or Stroke from Yaz or Yasmin
    Pulmonary Embolism from Yaz or Yasmin
    Deep Vein Thrombosis from Yaz or Yasmin

There are still  more than 5,000 additional claims involving a thrombosis blood clot related injury.  Bayer is continuing negotiating on a case-by-case basis, after complete documentation and presentation of the claim by an attorney. It is not too late to file your Yaz blood clot lawsuit. Our Yaz lawyers are still  continuing to review and evaluate potential claims from women who suffered a pulmonary embolism, deep vein thrombosis, heart attack, stroke or other blood clot injury while using Yaz, Yasmin or Ocella.

If you or a loved one has been injured by Yaz or a loved one has died from a Yaz related injury call us for a Yaz lawyer today.
 

Trials for failed DePuy Hip Replacements Ready to Begin, DePuy lawyers Accepting Cases Now

Written by Class Action Lawyer on . Posted in Arizona Multidistrict Litigation Lawyers, California Multidistrict Litigation Lawyers, Colorado Multidistrict Litigation Lawyers, Connecticut Multidistrict Litigation Lawyers, Florida Multidistrict Litigation Lawyers, Georgia Multidistrict Litigation Lawyers, Indiana Multidistrict Litigation Lawyers, Iowa Multidistrict Litigation Lawyers, Kansas Multidistrict Litigation Lawyers, Maryland Multidistrict Litigation Lawyers, Massachusetts Multidistrict Litigation Lawyers, Michigan Multidistrict Litigation Lawyers, Nevada Multidistrict Litigation Lawyers, New Jersey Multidistrict Litigation Lawyers, New Mexico Multidistrict Litigation Lawyers, New York Multidistrict Litigation Lawyers, North Carolina Multidistrict Litigation Lawyers

DePuy Hip Recall trials ready to begin. DePuy Hip Replacement Lawyers accepting cases in many states. If , need revision surgery or have had revision surgery or metal on  metal toxicity we want to speak to you right away. Only claim in state with 2 year statutes or greater are being accepted. Call right away as time is running out. If you have complications from your dePuy hip replacement see a doctor immediately
The first bellwether trials in the pending DePuy hip litigation are scheduled to begin later this year. The handful of plaintiffs involved in the trials represent just a few of the thousands of individuals who filed suit against Johnson & Johnson and DePuy Orthopedics after being injured by a defective metal hip implant. mny of these have been seniors needing revision surgeries.

According to a Bloomberg report, the first bellwether case is scheduled to go to trial in a Nevada court in December of this year. Additional bellwether trials are expected to begin in January 2013. According to the report, these cases are part of an estimated 2,000 DePuy hip lawsuits filed in state courts across the country. Several thousand more lawsuits are also pending in federal court after being consolidated into a multidistrict litigation (MDL) for pretrial proceedings. The plaintiffs involved in the DePuy hip litigation allege that they experienced pain, swelling, tissue damage, loss of mobility and other complications after being fitted with an ASR all-metal hip implant.  The lawsuits also allege that DePuy and Johnson & Johnson knew of potential problems with the metal hip replacement devices but did not take adequate steps to warn consumers of the dangers.

DePuy Orthopaedics issued a global recall of the ASR Hip Resurfacing System and ASR Acetabular System in August 2010, after data from the National Joint Registry of England and Wales showed that 1 out of every 8 patients (12%-13%) who had received the devices had to undergo revision surgery within five years of receiving it. According to Parker Waichman LLP, more than 93,000 metal-on-metal DePuy ASR hip implants were sold worldwide prior to their recall.

The U.S. Food & Drug Administration (FDA) is currently conducting a safety review of metal-on-metal hip implants, including the DePuy ASR devices. Last May, the agency directed 21 companies that market all-metal hip replacements, including DePuy, to conduct post-market studies of their products to determine if they were shedding dangerous amounts of metallic debris in patients. The FDA recently announced that its Orthopaedic and Rehabilitation Devices Panel will meet on June 27 and 28 to discuss the risks and benefits of metal-on-metal hip systems, and make potential patient and practitioner recommendations for their use.

It is strongly urged that anyone who has a failed DePuy see their Doctor immediately to find out if revision surgery is recommended and speak to a DePuy Lawyer right away

 

 

Birth Control Pills Label Change, Risk of Blood Clots, Birth Contol Pills Lawyers

Written by Class Action Lawyer on . Posted in Class MDL Class Action News

Birth Control Pills Containing Drospirenone: Label Change-Products may be associated with a higher risk for blood clots. Injury lawyers accepting cases for blood clots from yaz or Yasmin. Yaz is just another one of the dangerous drugs and medical devices harming women like the vaginal mesh and Mirena IUD. If you have been injured by Yaz, yasmin, the Mirena IUD, The Vaginal Mesh or any other you must take action and contact a lawyer immediately. Different states have different statutes of limitations, Do Not wait. Time is not on your side. You must get medical attention. Your lawyer will need a statement from a treating physician that says you were injured and it is related to one of these.
April 10, 2012

Yasmin Side Effects, Yaz side effects include bood clots. Speak to a Yaz, Yasmin lawyer today.
 

Audience: OBGYN, Family Practice, Patient

ISSUE: FDA has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills.Based on this review, FDA has concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills.

BACKGROUND:  Drospirenone is a synthetic version of the female hormone, progesterone, also referred to as a progestin. FDA is adding information about the studies to the labels of drospirenone-containing birth control pills.

The revised drug labels will report that some epidemiologic studies reported as high as a three-fold increase in the risk of blood clots for drospirenone-containing products when compared to products containing levonorgestrel or some other progestins, whereas other epidemiological studies found no additional risk of blood clots with drospirenone-containing products.  The labels also will include a summary of the previously released results of an FDA-funded study of the blood clot risk.

RECOMMENDATION: Women should talk to their healthcare professional about their risk for blood clots before deciding which birth control method to use.

Healthcare professionals should consider the risks and benefits of drospirenone-containing birth control pills and a woman’s risk for developing a blood clot before prescribing these drugs.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program. If you or a loved on as a blood clot injury or deathe due to Yaz or Yasmin Birth control piils call our Yaz, yasmin team today.